Altre lingue NanJing Pharmaceutical Company Limited

Azioni

600713

CNE000000KV1

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 11/07/2024			Variaz. 5gg	Var. 1 gen.
4,33 ^CNY	+2,12%		-0,23%	-10,54%

28/05	Nanjing Pharmaceutical emette obbligazioni a brevissimo termine per 500 milioni di yuan	MT
29/04	NanJing Pharmaceutical Company Limited riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds	28/05
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	08/04
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	07/04
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index	18/09/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.	21/12/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	23/08/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million	21/02/22
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd	14/02/22
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.	09/11/21
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd	10/09/21
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	20/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue NanJing Pharmaceutical Company Limited

Azioni

600713

CNE000000KV1

Altre lingue

Filtri